Fund shareholders of CELLECTAR BIOSCIENCES INC
ISIN US15117F8804 · United States · LEI 5493000NFZCRG7BYQV93
- Fund shareholders
- 8
- Of which ETFs
- 0 8 other funds
- Value held
- ≈ 1.1M $ 1M $ · 45.4K €
- Share of capital
- 3.8 % of 9.5M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 184,145 | 511.9K $ | 1.95 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 143,222 | 398.2K $ | 0.00 % | 1.52 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 26,977 | 84.7K $ | 0.00 % | 0.29 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 5,641 | 17.7K $ | 0.06 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,064 | 6.5K $ | 0.02 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 200 | 628 $ | 0.00 % | as of May 31, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1 | 2.8 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 45.4K € | 0.24 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 0.24 % | as of Dec 31, 2025 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 7 | 0 | 362,250 | +229.2 % |
| 2026Q2 | 7 | -1 | 110,048 | +9.6 % |
| 2026Q1 | 8 | -1 | 100,425 | +43.1 % |
| 2025Q4 | 9 | +4 | 70,200 | +16.3 % |
| 2025Q3 | 5 | 60,381 |
Institutional managers
16 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Bleichroeder LP | 100,000 | 254K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 52,778 | 134.1K $ | as of Mar 31, 2026 |
| Sequoia Financial Advisors, LLC | 18,850 | 47.9K $ | as of Mar 31, 2026 |
| Warberg Asset Management LLC | 13,900 | 35.3K $ | as of Mar 31, 2026 |
| Riverview Capital Advisers, LLC | 10,384 | 50.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 9,647 | 24.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,745 | 12.1K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 793 | 2K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 510 | 1.3K $ | as of Mar 31, 2026 |
| TD Waterhouse Canada Inc. | 63 | 154 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 11 | 28 $ | as of Mar 31, 2026 |
| FMR LLC | 10 | 25 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 3 | 8 $ | as of Mar 31, 2026 |
| US BANCORP \DE\ | 3 | 8 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 2 | 5 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of CELLECTAR BIOSCIENCES INC
There are 6 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. and 4 others | 9.99 % | 798,382 | as of Jun 30, 2026 · SCHEDULE 13G |
| Bleichroeder LP and 2 others | 9.99 % | 808,300 | as of Jun 30, 2026 · SCHEDULE 13G |
| Empery Asset Management, LP and 1 other | 9.99 % | 864,090 | as of Jun 30, 2026 · SCHEDULE 13G |
| SilverArc Capital Management, LLC and 1 other | 9.99 % | 851,285 | as of Jun 30, 2026 · SCHEDULE 13G |
| StemPoint Capital LP and 2 others | 9.90 % | 845,740 | as of Jun 30, 2026 · SCHEDULE 13G |
| Caligan Partners LP and 1 other | 5.90 % | 469,998 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of CELLECTAR BIOSCIENCES INC". https://titelia.com/en/stocks/cellectar-biosciences-inc-US15117F8804